BlackRock Health Sciences Term Trust (NYSE:BMEZ) Short Interest Up 188.0% in March

BlackRock Health Sciences Term Trust (NYSE:BMEZ) saw a significant growth in short interest in March. As of March 13th, there was short interest totaling 36,205 shares, a growth of 188.0% from the February 26th total of 12,573 shares. Based on an average trading volume of 225,332 shares, the short-interest ratio is presently 0.2 days. Based on an average trading volume of 225,332 shares, the short-interest ratio is presently 0.2 days.

BlackRock Health Sciences Term Trust Stock Performance

Shares of NYSE BMEZ traded up $0.21 during mid-day trading on Wednesday, reaching $14.02. 309,832 shares of the company traded hands, compared to its average volume of 283,443. The company’s fifty day moving average is $14.89 and its two-hundred day moving average is $14.91. BlackRock Health Sciences Term Trust has a fifty-two week low of $12.58 and a fifty-two week high of $15.80.

BlackRock Health Sciences Term Trust Announces Dividend

The firm also recently declared a monthly dividend, which will be paid on Tuesday, June 30th. Investors of record on Monday, June 15th will be given a $0.11 dividend. This represents a c) annualized dividend and a yield of 9.4%. The ex-dividend date of this dividend is Monday, June 15th.

Hedge Funds Weigh In On BlackRock Health Sciences Term Trust

A number of hedge funds have recently modified their holdings of the stock. CWM LLC boosted its stake in BlackRock Health Sciences Term Trust by 25.6% in the 4th quarter. CWM LLC now owns 3,336 shares of the company’s stock valued at $50,000 after buying an additional 680 shares in the last quarter. Steward Partners Investment Advisory LLC raised its stake in BlackRock Health Sciences Term Trust by 4.9% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 14,687 shares of the company’s stock worth $221,000 after acquiring an additional 688 shares in the last quarter. Chapin Davis Inc. lifted its holdings in shares of BlackRock Health Sciences Term Trust by 3.2% during the third quarter. Chapin Davis Inc. now owns 27,605 shares of the company’s stock valued at $398,000 after acquiring an additional 849 shares during the period. Private Advisor Group LLC boosted its stake in shares of BlackRock Health Sciences Term Trust by 3.5% in the 3rd quarter. Private Advisor Group LLC now owns 28,039 shares of the company’s stock valued at $404,000 after purchasing an additional 940 shares in the last quarter. Finally, Brown Lisle Cummings Inc. boosted its stake in shares of BlackRock Health Sciences Term Trust by 3.4% in the 3rd quarter. Brown Lisle Cummings Inc. now owns 46,666 shares of the company’s stock valued at $673,000 after purchasing an additional 1,554 shares in the last quarter.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.